I
Ida Martinelli
Researcher at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Publications - 241
Citations - 14689
Ida Martinelli is an academic researcher from Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. The author has contributed to research in topics: Thrombophilia & Venous thrombosis. The author has an hindex of 60, co-authored 230 publications receiving 12727 citations. Previous affiliations of Ida Martinelli include VU University Amsterdam & New York University.
Papers
More filters
Journal ArticleDOI
High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
TL;DR: Mutations in the prothrombin gene and the factor V gene are associated with cerebral-vein thrombosis and the use of oral contraceptives is strongly and independently associated with the disorder.
Journal ArticleDOI
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.
Vittorio Pengo,Gentian Denas,Giacomo Zoppellaro,Seena Padayattil Jose,Ariela Hoxha,Amelia Ruffatti,Laura Andreoli,Angela Tincani,Caterina Cenci,Domenico Prisco,Tiziana Fierro,Paolo Gresele,Arturo Cafolla,Valeria De Micheli,Angelo Ghirarduzzi,Alberto Tosetto,Anna Falanga,Ida Martinelli,Sophie Testa,Doris Barcellona,Maria Gerosa,Alessandra Banzato +21 more
TL;DR: The use of rivaroxaban in high-risk patients with antiphospholipid syndrome was associated with an increased rate of events compared with warfarin, thus showing no benefit and excess risk.
Journal ArticleDOI
The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation
V. De Stefano,Ida Martinelli,P. M. Mannucci,Katia Paciaroni,Patrizia Chiusolo,I Casorelli,E. Rossi,Giuseppe Leone +7 more
TL;DR: Carriers of both factor V Leiden and the G20210A prothrombin mutation have an increased risk of recurrent deep venous thrombosis after a first episode and are candidates for lifelong anticoagulation.
Journal ArticleDOI
EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients
Karl M. Einhäupl,Jan Stam,Marie-Germaine Bousser,S. F. T. M. De Bruijn,José M. Ferro,Ida Martinelli,F. Masuhr +6 more
TL;DR: Cerebral venous and sinus thrombosis is a rather rare disease which accounts for <1% of all strokes and current therapeutic measures include the use of anticoagulants such as dose‐adjusted intravenous heparin or body weight‐adjusted subcutaneous low‐molecular‐weightHeparin (LMWH).
Journal ArticleDOI
European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology
José M. Ferro,Marie-Germaine Bousser,Patrícia Canhão,Jonathan M. Coutinho,Isabelle Crassard,Francesco Dentali,M. N. D. Di Minno,Alberto Maino,Ida Martinelli,F. Masuhr,D. Aguiar de Sousa,Jan Stam +11 more
TL;DR: Current guidelines on cerebral venous thrombosis diagnosis and management were issued by the European Federation of Neurological Societies in 2010 are updated using a clearer and evidence‐based methodology.